254 results on '"Trachtenberg, Barry H."'
Search Results
2. Surgical risks
3. Contributors
4. Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study
5. Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy
6. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis
7. Association between digoxin use and gastrointestinal bleeding in contemporary continuous flow left ventricular assist device support
8. A principal components analysis of factors associated with successful implementation of an LVAD decision support tool
9. Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
10. Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
11. Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
12. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
13. Acquired and Hereditary Hypercoagulable States in Patients with Continuous Flow Left Ventricular Assist Devices: Prevalence and Thrombotic Complications
14. Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.
15. Persistent Blood Stream Infection in Patients Supported With a Continuous-Flow Left Ventricular Assist Device Is Associated With an Increased Risk of Cerebrovascular Accidents
16. Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
17. Roads, Maps, and Destinations: the Journey of Left Ventricular Assist Device Implantation in Ambulatory Patients with Advanced Heart Failure
18. Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation
19. Echocardiographic Evaluation of Hemodynamics in Patients With Systolic Heart Failure Supported by a Continuous-Flow LVAD
20. A simplified echocardiographic technique for detecting continuous-flow left ventricular assist device malfunction due to pump thrombosis
21. 6 - Surgical risks
22. Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation
23. Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk Patient
24. Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure
25. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
26. Validating an Idiopathic Dilated Cardiomyopathy Diagnosis Using Cardiovascular Magnetic Resonance: The Dilated Cardiomyopathy Precision Medicine Study
27. Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device
28. Inflammatory Cardiomyopathic Syndromes
29. Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial.
30. Targeted treatments of AL and ATTR amyloidosis
31. Presence of the V122I Variant of Hereditary Transthyretin-Mediated Amyloidosis Among Self-Reported White Individuals in a Sponsored Genetic Testing Program
32. Effectiveness of the Family Heart TalkCommunication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial
33. Biomarkers of Oxidative Stress in Heart Failure
34. Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation
35. Additional file 1 of Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
36. Additional file 2 of Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
37. Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer
38. Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial
39. Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity
40. Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
41. A Principal Components Analysis of Factors Associated with Successful Implementation of an LVAD Decision Support Tool
42. Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy.
43. Contributors
44. Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis
45. Safety of serial MRI in patients with implantable cardioverter defibrillators
46. Shared Decision Making In Cardiology Practice: 15 Month Results of A Multi-Site Study of Decision Aid Implementation
47. Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity
48. Should We Be for ASCT?
49. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis
50. Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.